Cuprous oxide nanoparticles inhibit angiogenesis via down regulation of VEGFR2 expression. (Q54379435)

29 May 2018

title

Cuprous oxide nanoparticles inhibit angiogenesis via down regulation of VEGFR2 expression. (English)

1 reference

29 May 2018

0 references

Hongyuan Song

1

1 reference

29 May 2018

Wenbo Wang

2

1 reference

29 May 2018

Ping Zhao

3

1 reference

29 May 2018

Zhongtian Qi

4

1 reference

29 May 2018

Shihong Zhao

5

1 reference

29 May 2018

language of work or name

English

0 references

publication date

5 February 2014

1 reference

29 May 2018

published in

Nanoscale

1 reference

29 May 2018

volume

6

1 reference

29 May 2018

issue

6

1 reference

29 May 2018

page(s)

3206-3216

1 reference

29 May 2018

Multifunctional nanoparticles for multimodal imaging and theragnosis

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Nanomedicine, nanotechnology in medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Biological properties of "naked" metal nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Cardiovascular toxicity evaluation of silica nanoparticles in endothelial cells and zebrafish model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Silver nano - a trove for retinal therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

The inhibition of retinal neovascularization by gold nanoparticles via suppression of VEGFR-2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

The inhibition of advanced glycation end-products-induced retinal vascular permeability by silver nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Copper oxide nanocrystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Effects of Cu2O nanoparticle and CuCl2 on zebrafish larvae and a liver cell-line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Molecular mechanisms and clinical applications of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

VEGF receptor signalling - in control of vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

VEGF-targeted therapy: mechanisms of anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Suppression of VEGFR2 Expression in Human Endothelial Cells by Dimethylfumarate Treatment: Evidence for Anti-Angiogenic Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Cuprous oxide nanospheres as probes for light scattering imaging analysis of live cells and for conformation identification of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Proliferation, cell cycle and apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Silver nanoparticles inhibit VEGF-and IL-1beta-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Gold nanoparticles: opportunities and challenges in nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Adverse effects of anticancer agents that target the VEGF pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Antiangiogenic properties of gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Antiangiogenic properties of silver nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

The potential of nanomedicine therapies to treat neovascular disease in the retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Zinc oxide nanoflowers make new blood vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

New roles for copper metabolism in cell proliferation, signaling, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Copper complexes as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

A novel role for copper in Ras/mitogen-activated protein kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Copper stimulates growth of human umbilical vein endothelial cells in a vascular endothelial growth factor-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Metals in anticancer therapy: copper(II) complexes as inhibitors of the 20S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Molecular regulation of angiogenesis and lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Vascular endothelial growth factor receptor-2 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK/STAT3 signaling in endothelial cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Cell cycle kinases as therapeutic targets for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Dentin matrix protein 1 induces membrane expression of VE-cadherin on endothelial cells and inhibits VEGF-induced angiogenesis by blocking VEGFR-2 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

Gold Nanoparticles Inhibit VEGF165-Induced Proliferation of HUVEC Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR04363K

21 January 2018

Identifiers

DOI

10.1039/C3NR04363K

1 reference

29 May 2018

1 reference

29 May 2018